Find information on thousands of medical conditions and prescription drugs.

Human parvovirus B19 infection

Parvovirus B19 (B19 virus) was the first human parvovirus to be discovered, by chance in 1975 by the Australian virologist Yvonne Cossart. It gained its name because it was discovered in well B19 of a large series of petri dishes apparently numbered in this way. more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Parovirus B19 is best known for causing a childhood exanthem called "fifth disease" (erythema infectiosum).

Virology

The B19 virus belongs to the Parvoviridae family of small DNA viruses. It is classified as Erythrovirus because of its capability to invade red blood cell precursors in the bone marrow.

Transmission

The virus is spread by infected respiratory droplets. The secondary attack risk for exposed household persons is about 50%, and about half of that for classroom contacts.

Infectivity

B19 symptoms begins some six days after exposure and last about a week. Infected patients with normal immune systems are contagious before becoming symptomatic, but probably not after then.

Persons with B19 IgG antibodies are generally considered immune to recurrent infection, but reinfection is possible in a minority of cases. About half of adults are B19-immune due to a past infection.

Epidemiology

A significant increase in the number of cases is seen every three to four years; the last epidemic year was 1998. Outbreaks can arise especially in nurseries and schools.

Parvovirus B19 causes an infection in humans only; cat and dog parvoviruses do not infect humans. In contrast with small animals, there is no vaccine available for human parvovirus B19.

Role in disease

Fifth disease

After being infected, patients usually develop the illness after an incubation period of four to fourteen days. The disease commences with fever and malaise while the virus is most abundant in the bloodstream, and patients are usually no longer infectious once the characteristic rash of this disease has appeared.

Any age may be affected, although it is most common in children aged six to ten years.

Arthritis

In adults (and perhaps some children), parvovirus B19 can lead to a seronegative arthritis which is easily controlled with analgesics. Possibly up to 15% of all new cases of arthritis are due to parvovirus, and a history of recent contact with a patient and positive serology generally confirms the diagnosis. This arthritis does not progress to other forms of arthritis.

Aplastic crisis

Although most patients have an arrest of erythropoiesis (production of red blood cells) during parvovirus infection, it causes worse problems in patients with sickle cell anemia, who are heavily dependant on erythropoeisis due to the reduced lifespan of the red cells. This is termed "aplastic crisis". It is treated with blood transfusion. Sickle-cell patients will probably be the first candidates for a parvovirus B19 vaccine when it is developed.

Read more at Wikipedia.org


[List your site here Free!]


Human Parvovirus B19 (Monographs in Virology) $70.00 Human parvovirus B19: Clinical consequences of infection

Presentation of parvovirus B19 infection varies
The parvovirus family includes many viruses that infect a variety of animal species. In humans, parvovirus B19 has the most clinical significance. It ...
Laboratory diagnosis of acute human parvovirus B19 infection by specific IgM detection
Jussara P. NASCIMENTO(1,4), Alicia MISTCHENKO(2) &Bernard J. COHEN(3) KEYWORDS: Human parvovirus B19; Ig M detection; Diagnosis The laboratory diagnosis ...
Study of chronic hemolytic anaemia patients in Rio De Janeiro: Prevalence of anti-human parvovirus B19 IgG antibodies and the development of transient
SUMMARY The prevalence of anti-human parvovirus B 19 IgG antibodies was determined in sera from 165 chronic hemolytic anemia patients, receiving medical ...
A pilot study on the seroprevalence of parvovirus B19 infection
Background & objectives: Human parvovirus B 19 (PVB 19) causes aplastic crisis in children with congenital haemolytic anaemia, erythema infectiosum, abortion ...
Association between human parvovirus B19 and arthropathy in Belem, Para, North Brazil
SUMMARY A total of 220 patients with arthropathy were selected in Belem, Para between January 1994 and December 2000, and screened for the presence of ...
Parvovirus B19 Infections
Infections caused by human parvovirus B19 can result in a wide spectrum of manifestations, which are usually influenced by the patient's immunologic ...
Human parvovirus infection
Human Parvovirus Infection Fifth disease (erythema infectiosum) has recently been linked to human parvovirus (HPV) infection. HPV is also capable of causing aplastic anemia, arthritis and perinatal
Parvovirus Infection
(Great Britain-The Practitioner, September 1999, p. 672.) Fifth disease, or erythema infectiosum, is the most familiar clinical manifestation of parvovirus ...

Home Contact Resources Exchange Links ebay